Cargando…
Advanced glycation end products induce the apoptosis of and inflammation in mouse podocytes through CXCL9-mediated JAK2/STAT3 pathway activation
Diabetic nephropathy (DN) is a serious and one of the most common microvascular complications of diabetes. There is accumulating evidence to indicate that advanced glycation end products (AGEs), senescent macroprotein derivatives formed at an accelerated rate under conditions of diabetes, play a rol...
Autores principales: | Yu, Jing, Wu, Hao, Liu, Zi-Yu, Zhu, Qi, Shan, Chang, Zhang, Ke-Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593472/ https://www.ncbi.nlm.nih.gov/pubmed/28849106 http://dx.doi.org/10.3892/ijmm.2017.3098 |
Ejemplares similares
-
DJC Suppresses Advanced Glycation End Products-Induced JAK-STAT Signaling and ROS in Mesangial Cells
por: Sun, Min, et al.
Publicado: (2017) -
Advanced-Glycation End-Products Induce Podocyte Injury and Contribute to Proteinuria
por: Nishad, Rajkishor, et al.
Publicado: (2021) -
C9ORF72 suppresses JAK-STAT mediated inflammation
por: Pang, Weilun, et al.
Publicado: (2023) -
Delamanid suppresses CXCL10 expression via regulation of JAK/STAT1 signaling and correlates with reduced inflammation in tuberculosis patients
por: Qiao, Min, et al.
Publicado: (2022) -
Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells
por: Fenwick, Peter S., et al.
Publicado: (2015)